Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens

Abstract Background Etravirine (ETR), a non-nucleoside reverse transcriptase inhibitor (NNRTI) available in France since 2006, is indicated for antiretroviral-experienced HIV-infected adults, in combination with a ritonavir-boosted protease inhibitor (PI). To assess its clinical impact in routine ca...

Cijeli opis

Bibliografski detalji

Glavni autori:	Valérie Potard, Cécile Goujard, Marc Antoine Valantin, Jean Marc Lacombe, Rima Lahoulou, Arnaud Chéret, Pierre Marie Girard, Dominique Costagliola, French Hospital Database on HIV (FHDH - ANRS CO4)
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2018-07-01
Serija:	BMC Infectious Diseases
Teme:	Antiretroviral experienced HIV-infected individuals Etravirine Hospitalization rates
Online pristup:	http://link.springer.com/article/10.1186/s12879-018-3231-5
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!